Regen BioPharma Inc Pref Share RGBPP
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.06
- Bid/Ask
- $0.00 / $0.08
- Shares Outstanding
- —
- Market Cap
- $10,123.77
- Volume/Avg
- 605,509 / 751,523
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Regen BioPharma Inc is a USA-based biotechnology company. It focuses on the development of regenerative medical applications in the stem cell space. The company's principal products and services include HemaXellarate I, HemaXellerate II, dCell Vax, NR2F6, Tcellvax, identification of Small Molecules, and others. HemaXellarate I and HemaXellerate II are cellular therapies designed to heal damaged bone marrow. dCell Vax is a therapy whereby dendritic cells of the cancer patient are harvested from the body. Tcellvax is an autologous cellular product comprised of NR2F6 gene-silenced peripheral blood mononuclear cells.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- 1
Valuation
Metric | RGBPP |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric | RGBPP |
|---|---|
Quick Ratio | 0.05 |
Current Ratio | 0.05 |
Interest Coverage | −4.63 |
Quick Ratio
RGBPP
Profitability
Metric | RGBPP |
|---|---|
Return on Assets (Normalized) | −472.08% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
RGBPP
Biotechnology Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc VRTX | LOCK|$R!z@& | LOCK|!^SP | $131B | |||
| Regeneron Pharmaceuticals Inc REGN | LOCK|FlH$J# | LOCK|%!Q< | $95B | |||
| Moderna Inc MRNA | LOCK|j^Pr$>^ | LOCK|&B | $79B | |||
| argenx SE ADR ARGX | LOCK|%CK#s%T | LOCK|m!f | $59B | |||
| BeOne Medicines Ltd ADR ONC | LOCK|Fw<%JQ | LOCK|>q | $45B | |||
| Royalty Pharma PLC Class A RPRX | LOCK|K<#ZB&Dn | LOCK|$$Kc% | $30B | |||
| Incyte Corp INCY | LOCK|PZ!W>w& | LOCK|yKX | $23B | |||
| BioNTech SE ADR BNTX | LOCK|Fkj<$s@ | LOCK|Sy | $20B | |||
| Alnylam Pharmaceuticals Inc ALNY | LOCK|wqz%^<^ | LOCK|QVH$ | $19B | |||
| BridgeBio Pharma Inc BBIO | LOCK|F$B&tM? | LOCK|>$w | $15B |